BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19893527)

  • 1. Anticipating the perceived risk of nanotechnologies.
    Satterfield T; Kandlikar M; Beaudrie CE; Conti J; Herr Harthorn B
    Nat Nanotechnol; 2009 Nov; 4(11):752-8. PubMed ID: 19893527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of risk from nanotechnologies and trust in stakeholders: a cross sectional study of public, academic, government and business attitudes.
    Capon A; Gillespie J; Rolfe M; Smith W
    BMC Public Health; 2015 Apr; 15():424. PubMed ID: 25928741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vulnerability and social justice as factors in emergent U.S. nanotechnology risk perceptions.
    Conti J; Satterfield T; Harthorn BH
    Risk Anal; 2011 Nov; 31(11):1734-48. PubMed ID: 21453374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deliberating the risks of nanotechnologies for energy and health applications in the United States and United Kingdom.
    Pidgeon N; Harthorn BH; Bryant K; Rogers-Hayden T
    Nat Nanotechnol; 2009 Feb; 4(2):95-8. PubMed ID: 19197310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fairness and nanotechnology concern.
    McComas KA; Besley JC
    Risk Anal; 2011 Nov; 31(11):1749-61. PubMed ID: 21883336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public optimism towards nanomedicine.
    Bottini M; Rosato N; Gloria F; Adanti S; Corradino N; Bergamaschi A; Magrini A
    Int J Nanomedicine; 2011; 6():3473-85. PubMed ID: 22267931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes and attitudinal ambivalence change towards nanotechnology applied to food production.
    Fischer AR; van Dijk H; de Jonge J; Rowe G; Frewer LJ
    Public Underst Sci; 2013 Oct; 22(7):817-31. PubMed ID: 23825237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of nanomaterials in dentistry: covariates of risk and benefit perceptions among dentists and dental hygienists in Norway.
    Xenaki V; Costea DE; Marthinussen MC; Cimpan MR; Åstrøm AN
    Acta Odontol Scand; 2020 Mar; 78(2):152-160. PubMed ID: 31561718
    [No Abstract]   [Full Text] [Related]  

  • 9. Perceived risks and perceived benefits of different nanotechnology foods and nanotechnology food packaging.
    Siegrist M; Stampfli N; Kastenholz H; Keller C
    Appetite; 2008 Sep; 51(2):283-90. PubMed ID: 18406006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding public perceptions of benefits and risks of childhood vaccinations in the United States.
    Song G
    Risk Anal; 2014 Mar; 34(3):541-55. PubMed ID: 24033739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology and society: the evolution of risk perceptions.
    Kahan DM
    Nat Nanotechnol; 2009 Nov; 4(11):705-6. PubMed ID: 19898518
    [No Abstract]   [Full Text] [Related]  

  • 12. Occupational safety and health's role in sustainable, responsible nanotechnology: gaps and needs.
    Iavicoli S; Rondinone BM; Boccuni F
    Hum Exp Toxicol; 2009 Jun; 28(6-7):433-43. PubMed ID: 19755456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public acceptance of nanotechnology foods and food packaging: the influence of affect and trust.
    Siegrist M; Cousin ME; Kastenholz H; Wiek A
    Appetite; 2007 Sep; 49(2):459-66. PubMed ID: 17442455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnologies in agriculture and food - an overview of different fields of application, risk assessment and public perception.
    Grobe A; Rissanen ME
    Recent Pat Food Nutr Agric; 2012 Dec; 4(3):176-86. PubMed ID: 23013411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value predispositions as perceptual filters: Comparing of public attitudes toward nanotechnology in the United States and Singapore.
    Liang X; Ho SS; Brossard D; Xenos MA; Scheufele DA; Anderson AA; Hao X; He X
    Public Underst Sci; 2015 Jul; 24(5):582-600. PubMed ID: 24292230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert views on regulatory preparedness for managing the risks of nanotechnologies.
    Beaudrie CE; Satterfield T; Kandlikar M; Harthorn BH
    PLoS One; 2013; 8(11):e80250. PubMed ID: 24244662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cultural cognition of the risks and benefits of nanotechnology.
    Kahan DM; Braman D; Slovic P; Gastil J; Cohen G
    Nat Nanotechnol; 2009 Feb; 4(2):87-90. PubMed ID: 19197308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology in Dutch science cafés: Public risk perceptions contextualised.
    Dijkstra AM; Critchley CR
    Public Underst Sci; 2016 Jan; 25(1):71-87. PubMed ID: 24812210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bottom-up risk regulation? How nanotechnology risk knowledge gaps challenge federal and state environmental agencies.
    Powell MC; Griffin MP; Tai S
    Environ Manage; 2008 Sep; 42(3):426-43. PubMed ID: 18543023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Envisioning emerging nanotechnologies: a three-year panel study of South Carolina citizens.
    Priest S; Lane T; Greenhalgh T; Hand LJ; Kramer V
    Risk Anal; 2011 Nov; 31(11):1718-33. PubMed ID: 21992651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.